Form 4 Filing for Structure Therapeutics Inc. - Director Daniel G. Welch

This filing reports a Form 4 for Structure Therapeutics Inc. concerning transactions by director Daniel G. Welch. On June 17, 2026, Mr. Welch was granted 39,453 share options with an exercise price of $15.00 per share. These options are for Ordinary Shares, with each American Depositary Share (ADS) representing three Ordinary Shares. The options vest monthly over 12 months starting from June 17, 2026, and will be fully vested by the date prior to the Issuer's 2027 annual shareholder meeting. The transaction is classified as an acquisition of securities.